PreView: The Preventive Video Education in Waiting Rooms Program

Not Applicable

Completed

• Conditions: Health Status Unknown
• Interventions: Other: Computer-Assisted Intervention; Other: Questionnaire Administration

• Registration Number: NCT02264782
• Lead Sponsor: University of California, San Francisco

Brief Summary

This clinical trial studies how well PreView, preventive video education, works in increasing rates of breast, cervical and colorectal cancer screening, improving participants' stage of change with respect to age appropriate cancer screening and increasing patient-provider discussions about prostate cancer screening.

Detailed Description

PRIMARY OBJECTIVES:

I. To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, pap tests, colon cancer tests or prostate specific antigen (PSA) testing discussions with primary care physicians compared with participants who receive usual care.

II. To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or colorectal cancer (CRC) compared with usual care.

III. To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

OUTLINE: Patients are randomized into 1 of 2 groups.

GROUP I: Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.

GROUP II: Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.

Study Timeline

• Study Start: 2013-07
• Study First Submitted: 2014-10-06
• Study First Submitted QC: 2014-10-09
• Study First Posted: 2014-10-15
• Primary Completion: 2019-02
• Study Completion: 2019-03
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-20
• Last Update Posted: 2020-07-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 508

Inclusion Criteria

• Without a history of cancer

Exclusion Criteria

• With a history of cancer (for whom subsequent procedures would be surveillance and not screening)
• Individuals who do not speak English or Spanish (except for the testimonials)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group I (PreView)	Computer-Assisted Intervention	Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.
Group II (educational video)	Computer-Assisted Intervention	Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.
Group II (educational video)	Questionnaire Administration	Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.
Group I (PreView)	Questionnaire Administration	Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.

Primary Outcome Measures

Name	Time	Method
Increasing rates of breast, cervical and colorectal cancer screening	From Baseline up to 14 months	To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.
Changing participants' readiness to be screened for breast, cervical and colorectal cancer	Up to 3 hours from pre-visit to post-visit interview.	To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, Pap tests, colon cancer tests or PSA testing discussions with primary care physicians compared with participants who receive usual care
Increasing physician-patient discussions about PSA screening measured by chart review	Baseline up to 14 months	To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or CRC compared with usual care.

Trial Locations

Locations (2)

John Muir Medical Center-Concord Campus; 🇺🇸 Concord, California, United States

UCSF Medical Center-Mount Zion; 🇺🇸 San Francisco, California, United States